Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children

PHASE3RecruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

June 1, 2028

Study Completion Date

October 1, 2028

Conditions
Hemorrhagic ShockTrauma Injury
Interventions
BIOLOGICAL

Low Titer Group O Whole Blood (LTOWB)

LTOWB is whole blood from group O donors with low titer (\<200) anti-A and anti-B antibodies. Up to 8 units of LTOWB will be allowed unless local clinical practice allows for a higher maximum dose.

DRUG

Placebo

Placebo will be provided to the research pharmacy at each of the clinical sites

DRUG

Tranexamic Acid (TXA)

TXA is a synthetic lysine analog that competitively inhibit activation of plasminogen, thereby decreasing the conversion of plasminogen to plasmin, preventing degradation of fibrin's matrix structure. Dose is 25mg/kg IV or IO (maximum 2 grams).

BIOLOGICAL

Component Therapy (CT)

Component Therapy (CT) will be RBCs, plasma and platelet units in a 1:1:1 unit ratio. This will be given with Placebo

Trial Locations (23)

15224

RECRUITING

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

20010

RECRUITING

Children's National Hospital, Washington D.C.

27157

RECRUITING

Wake Forest University Health Sciences, Wake Forest

30329

RECRUITING

Emory University-Arthur M. Blank Hospital, Atlanta

30342

RECRUITING

Emory University-Scottish Rite Hospital, Atlanta

37232

NOT_YET_RECRUITING

Vanderbilt University Medical Center, Nashville

38103

RECRUITING

LeBonheur Children's Hospital, Memphis

39216

RECRUITING

University of Mississippi Medical Center, Jackson

43205

RECRUITING

Nationwide Children's Hospital, Columbus

53226

RECRUITING

Medical College of Wisconsin, Milwaukee

63110

RECRUITING

Washington University of St. Louis, St Louis

70118

RECRUITING

Tulane School of Medicine, New Orleans

72202

RECRUITING

Arkansas Children's Hospital, Little Rock

75390

RECRUITING

The University of Texas Southwestern Medical Center, Dallas

77030

RECRUITING

Baylor College of Medicine, Houston

RECRUITING

Children's Memorial Hermann Hospital, Houston

78229

RECRUITING

University of Texas Health Science Center at San Antonio, San Antonio

84112

RECRUITING

Primary Children's Hospital, Salt Lake City

84719

RECRUITING

University of Arizona, Tucson

87131

RECRUITING

University of New Mexico, Albuquerque

95817

RECRUITING

University of California Davis, Sacramento

97239

RECRUITING

Oregon Health and Science University, Portland

98195

RECRUITING

University of Washington Harborview, Seattle

All Listed Sponsors
collaborator

Biomedical Advanced Research and Development Authority

FED

lead

Philip Spinella

OTHER

NCT06070350 - Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children | Biotech Hunter | Biotech Hunter